Experimental Zika vaccine to begin human testing

An experimental vaccine for the Zika virus is due to begin human testing in coming weeks, after getting the green light from US health officials.

Inovio Pharmaceuticals said it received clearance from the Food and Drug Administration to begin early-stage safety tests of its DNA-based vaccine against the mosquito-borne virus.